Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Wider Q3 Loss; Gets EU Approval for New Bolus Use
Tweet Send to a FriendGet Alerts NXTM Hot Sheet
Price: $13.83 +1.69%
Revenue Growth %: +8.1%
Financial Fact:
Total operating expenses: 28.54M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: +8.1%
Financial Fact:
Total operating expenses: 28.54M
Today's EPS Names:
ANF, DXLG, FL, More
Trade NXTM Now!
Nxstage Medical, Inc. (NASDAQ: NXTM) reported Q2 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $59 million versus the consensus estimate of $58.22 million.
Nxstage Medical, Inc. sees Q3 2012 EPS of $-0.08-$-0.06, versus the consensus of $-0.05. Nxstage Medical, Inc. sees Q3 2012 revenue of $60-$61 million, versus the consensus of $61.93 million.
Separately, the Company announced that the European regulatory authority has approved a new feature to automate the administration of bolus for use in the EU.
For earnings history and earnings-related data on Nxstage Medical, Inc. (NXTM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Nxstage Medical, Inc. sees Q3 2012 EPS of $-0.08-$-0.06, versus the consensus of $-0.05. Nxstage Medical, Inc. sees Q3 2012 revenue of $60-$61 million, versus the consensus of $61.93 million.
Separately, the Company announced that the European regulatory authority has approved a new feature to automate the administration of bolus for use in the EU.
For earnings history and earnings-related data on Nxstage Medical, Inc. (NXTM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Williams-Sonoma, Inc. (WSM) Tops Q1 EPS by 4c; Boosts Outlook
Create E-mail Alert Related Categories
Earnings, FDA, Guidance, Hot GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
